What the research shows
- Better arm-function scores in stroke-rehab trial
- Early neurological benefit in 442 stroke patients
- Better 90-day outcomes in 185 brain-injury patients
Published study results for the compound, not results from this product. For research use only.
Cerebrolysin conventionally denotes a complex peptide-and-amino-acid preparation rather than one defined peptide. Genovare labels this 3mL pen as 60mg, but supplies no composition or mass-basis evidence establishing equivalence to an authorised Cerebrolysin formulation. No batch-specific independent report is linked, so identity, quantity and purity are unverified.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare Pre-Filled Pen Premixed Aqueous
SpecsCerebrolysin 60mg AQ Pen
Neuropeptide preparation studied in stroke-rehab trials
AED 700 / pen
Choose your bundle
Minimum order is AED 400
25% off orders of AED 700+ with code KV25 at checkout
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
- Sold by
- Remy Research
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Ships from Dubai
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | Cerebrolysin-labelled peptide preparation |
| Catalogue strength | 60 mg |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |